134 related articles for article (PubMed ID: 10576767)
1. Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.
García-Otín AL; Civeira F; Peinado-Onsurbe J; Gonzalvo C; Llobera M; Pocoví M
Eur J Endocrinol; 1999 Nov; 141(5):502-5. PubMed ID: 10576767
[TBL] [Abstract][Full Text] [Related]
2. Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia.
Wiebusch H; Funke H; Bruin T; Bucher H; von Eckardstein A; Kastelein JJ; Assmann G
Hum Mutat; 1996; 8(4):381-3. PubMed ID: 8956048
[No Abstract] [Full Text] [Related]
3. Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
Brümmer D; Evans D; Berg D; Greten H; Beisiegel U; Mann WA
J Mol Med (Berl); 1998 Apr; 76(5):355-64. PubMed ID: 9587070
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.
Minnich A; Kessling A; Roy M; Giry C; DeLangavant G; Lavigne J; Lussier-Cacan S; Davignon J
J Lipid Res; 1995 Jan; 36(1):117-24. PubMed ID: 7706936
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic response to medium-chain triglycerides and omega-3 fatty acids in a patient with the familial chylomicronemia syndrome.
Rouis M; Dugi KA; Previato L; Patterson AP; Brunzell JD; Brewer HB; Santamarina-Fojo S
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1400-6. PubMed ID: 9261273
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein lipase mutation S447X associated with pancreatic calcification and steatorrhea in hyperlipidemic pancreatitis.
Chang YT; Chang MC; Su TC; Liang PC; Su YN; Kuo CH; Wei SC; Wong JM
J Clin Gastroenterol; 2009 Jul; 43(6):591-6. PubMed ID: 19034041
[TBL] [Abstract][Full Text] [Related]
7. The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.
Henneman P; van der Sman-de Beer F; Moghaddam PH; Huijts P; Stalenhoef AF; Kastelein JJ; van Duijn CM; Havekes LM; Frants RR; van Dijk KW; Smelt AH
Eur J Hum Genet; 2009 May; 17(5):620-8. PubMed ID: 19034316
[TBL] [Abstract][Full Text] [Related]
8. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
[TBL] [Abstract][Full Text] [Related]
9. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism.
St-Amand J; Moorjanit S; Lupien PJ; Prud'homme D; Després JP
Metabolism; 1996 Feb; 45(2):261-7. PubMed ID: 8596500
[TBL] [Abstract][Full Text] [Related]
10. Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase.
Al-Shali K; Wang J; Fellows F; Huff MW; Wolfe BM; Hegele RA
Clin Biochem; 2002 Mar; 35(2):125-30. PubMed ID: 11983347
[TBL] [Abstract][Full Text] [Related]
11. Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia.
Stalenhoef AF; Casparie AF; Demacker PN; Stouten JT; Lutterman JA; van 't Laar A
Metabolism; 1981 Sep; 30(9):919-26. PubMed ID: 7266379
[TBL] [Abstract][Full Text] [Related]
12. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform.
Ma Y; Ooi TC; Liu MS; Zhang H; McPherson R; Edwards AL; Forsythe IJ; Frohlich J; Brunzell JD; Hayden MR
J Lipid Res; 1994 Jun; 35(6):1066-75. PubMed ID: 8077845
[TBL] [Abstract][Full Text] [Related]
13. Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis.
Hoffmann MM; Jacob S; Luft D; Schmülling RM; Rett K; März W; Häring HU; Matthaei S
J Clin Endocrinol Metab; 2000 Dec; 85(12):4795-8. PubMed ID: 11134145
[TBL] [Abstract][Full Text] [Related]
14. Postheparin plasma lipoprotein lipase activity in heterozygotes of familial lipoprotein lipase deficiency.
Kondo Y; Kurobane I; Omura K; Sano R; Abe R; Chida N; Tada K
Tohoku J Exp Med; 1985 Jan; 145(1):1-6. PubMed ID: 3983953
[TBL] [Abstract][Full Text] [Related]
15. A single Ser259Arg mutation in the gene for lipoprotein lipase causes chylomicronemia in Moroccans of Berber ancestry.
Foubert L; Bruin T; De Gennes JL; Ehrenborg E; Furioli J; Kastelein J; Benlian P; Hayden M
Hum Mutat; 1997; 10(3):179-85. PubMed ID: 9298816
[TBL] [Abstract][Full Text] [Related]
16. Identification and Characterization of Two Novel Compounds: Heterozygous Variants of
Wang S; Cheng Y; Shi Y; Zhao W; Gao L; Fang L; Jin X; Han X; Sun Q; Li G; Zhao J; Xu C
Front Endocrinol (Lausanne); 2022; 13():874608. PubMed ID: 35923617
[TBL] [Abstract][Full Text] [Related]
17. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Breier C
Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D
J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148
[TBL] [Abstract][Full Text] [Related]
19. Genotype-phenotype relationships in patients with type I hyperlipoproteinemia.
Chokshi N; Blumenschein SD; Ahmad Z; Garg A
J Clin Lipidol; 2014; 8(3):287-95. PubMed ID: 24793350
[TBL] [Abstract][Full Text] [Related]
20. Higher triglycerides, lower high-density lipoprotein cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report.
Sprecher DL; Harris BV; Stein EA; Bellet PS; Keilson LM; Simbartl LA
Circulation; 1996 Dec; 94(12):3239-45. PubMed ID: 8989135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
